Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians

被引:18
|
作者
Biswas, Arijit [1 ]
Ranjan, Ravi [1 ]
Meena, Arvind [1 ]
Akhter, Suhail [1 ]
Sharma, Vinita [1 ]
Yadav, Birendra Kumar [1 ]
Behari, Madhuri [1 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Hematol, New Delhi 110029, India
关键词
Factor V Leiden mutation; Factor V HR2 Haplotype; Coagulation Inhibitors; Factor VIII levels; Acute phase; Asian-Indians; ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; ISCHEMIC-STROKE; VENOUS THROMBOEMBOLISM; FACTOR V-R506Q; RESISTANCE; MUTATION; MARKERS; INACTIVATION; THROMBOPHILIA;
D O I
10.1016/j.thromres.2009.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Several prothrombotic factors - both hereditary and acquired - are known to cause stroke. Commonly investigated causes are activated protein C resistance, factor V Leiden mutation, factor VIII levels, prothrombin 20210 G-to-A mutation, coagulation inhibitors such as proteins C and S, and anti phospholipid antibodies such as beta(2)-glycoprotein. Objective: The literature on the prevalence of hematological defects pertaining to these variables in the Asian Indian stroke population is limited to a few isolated reports. In the current study we investigate the above-mentioned variables in 120 stroke patients (non-cardioembolic acute-onset stroke) and compare their status with the hematological profile of an equal number of healthy age- and sex-matched controls. Material and Methods: Plasma and blood leukocytes were collected from all patients and controls for performing hematological assays and molecular tests respectively. The mutations were detected using standard polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) procedures. Statistical analysis was done using SPSS version 12.0. Results: Factor V Leiden (prevalence 8.3% in patients) and activated protein C resistance (prevalence 19.6% in patients) both showed a high degree of association (P<0.01) with the disease condition. However, contrary to common expectations, factor V Leiden was observed much less frequently in patients showing activated protein C resistance (10 out of 23; 43.4%) than is commonly observed in the Caucasian population (almost 90%). Post-acute-phase factor VIII levels were also found to be significantly associated with stroke: 125.6 + 21.1% number of profitable positions (NPP) for controls and 136.2 + 28.8% NPP for patients (P = 0.001). Conclusion: factor V mutations, such as factor V Leiden, may be important risk factors for stroke in an Asian Indian population. Activated protein C resistance has a stronger association with stroke than factor V Leiden and may be caused by other factors such as elevated factor VIII levels in the Asian Indian population apart from factor V Leiden itself. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 50 条
  • [11] Monitoring of biological response to clopidogrel after treatment for non-cardioembolic ischemic stroke or transient ischemic attack
    Varvat, Jerome
    Montmartin, Aurelie
    Epinat, Magali
    Accassat, Sandrine
    Garcin, Arneuld
    Li, Guorong
    Gamier, Pierre
    Lambert, Claude
    Mismett, Patrick
    Mallouk, Nora
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 5332 - 5337
  • [12] Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Shah, Surendra Prasad
    Shrestha, Aashish
    Pandey, Sirish Raj
    Sigdel, Kaushal
    Sah, Namrata
    Panthi, Sagar
    Basnet, Lila Bahadur
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2022, 60 (247) : 241 - 245
  • [13] Comparison of right-to-left shunt characteristics in cryptogenic embolic ischemic stroke and non-cardioembolic ischemic stroke
    Scavasine, Valeria Cristina
    Chamma, Jamileh Ferreira
    Bazan, Rodrigo
    Braga, Gabriel Pereira
    Lange, Marcos Christiano
    Flumignan Zetola, Viviane de Hiroki
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (10) : 859 - 863
  • [14] Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial
    Balali, Pargol
    Hart, Robert G.
    Smith, Eric E.
    Saad, Feryal
    Colorado, Pablo
    Lemmens, Robin
    De Marchis, Gian Marco
    Caso, Valeria
    Xu, Lizhen
    Heenan, Laura
    Connolly, Stuart J.
    Mundl, Hardi
    Shoamanesh, Ashkan
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (05) : 526 - 535
  • [15] Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial
    Yamaguchi, Takenori
    Shirai, Toshiaki
    Yoshiba, Satoshi
    Abe, Kenji
    Ikeda, Yasuo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 10 - 17
  • [16] Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins
    David Brea
    Jaume Roquer
    Joaquín Serena
    Tomás Segura
    José Castillo
    BMC Neurology, 12
  • [17] Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins
    Brea, David
    Roquer, Jaume
    Serena, Joaquin
    Segura, Tomas
    Castillo, Jose
    BMC NEUROLOGY, 2012, 12
  • [18] Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial
    Kelly, Peter
    Weimar, Christian
    Lemmens, Robin
    Murphy, Sean
    Purroy, Francisco
    Arsovska, Anita
    Bornstein, Natan M.
    Czlonkowska, Anna
    Fischer, Urs
    Fonseca, Ana Catarina
    Forbes, John
    Hill, Michael D.
    Jatuzis, Dalius
    Korv, Janika
    Kruuse, Christina
    Mikulik, Robert
    Nederkoorn, Paul J.
    O'Donnell, Martin
    Sandercock, Peter
    Tanne, David
    Tsivgoulis, Georgios
    Walsh, Cathal
    Williams, David
    Zedde, Marialuisa
    Price, Christopher, I
    EUROPEAN STROKE JOURNAL, 2021, 6 (02) : 222 - 228
  • [19] Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel
    Kitazono, Takanari
    Ikeda, Yasuo
    Nishikawa, Masakatsu
    Yoshiba, Satoshi
    Abe, Kenji
    Ogawa, Akira
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 488 - 495
  • [20] Prothrombotic risk factors in ischemic stroke and migraine in children
    Pilarska, E.
    Lemka, M.
    Bakowska, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (01): : 13 - 16